Trials / Sponsors / Suzhou Forlong Biotechnology Co., Ltd
Suzhou Forlong Biotechnology Co., Ltd
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2026-01-08 |
| Recruiting | A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer Non-muscle Invasive Bladder Cancer (NMIBC) | Phase 1 / Phase 2 | 2024-08-16 |
| Active Not Recruiting | A Study of FL115 Monotherapy in Unresectable or Metastatic Solid Tumors Locally Advanced/Metastatic Solid Tumors | Phase 1 | 2024-05-30 |
| Completed | First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study Locally Advanced/Metastatic Solid Tumors | Phase 1 | 2023-12-30 |